Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terrence J Bradley

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Current Hematologic Malignancy Reports|September 30, 2018
Leveraging Hypomethylating Agents for Better MDS TherapyTerrence J Bradley, Justin M Watts, Ronan T Swords
Cancer Management and Research|August 8, 2022
Profile of Glasdegib for the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML): Evidence to DateSunil Girish Iyer, Michele Stanchina, Terrence J Bradley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2021
Clinical Responsiveness to All-trans Retinoic Acid Is Potentiated by LSD1 Inhibition and Associated with a Quiescent Transcriptome in Myeloid MalignanciesMina M Tayari, Helena G Dos Santos, Deukwoo Kwon, et al.
Cancer|September 15, 2022
Molecular annotation of extramedullary acute myeloid leukemia identifies high prevalence of targetable mutationsSomedeb Ball, Todd C Knepper, Yehuda E Deutsch, et al.
Ejhaem|May 14, 2025
Phase 2 Multi-Arm Study of Magrolimab Combinations in Patients With Acute Myeloid LeukaemiaGabriel N Mannis, Camille N Abboud, Naval G Daver, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 13, 2023
Tolerability and Efficacy of the Anticluster of Differentiation 47 Antibody Magrolimab Combined With Azacitidine in Patients With Previously Untreated AML: Phase Ib ResultsNaval G Daver, Paresh Vyas, Suman Kambhampati, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 8, 2023
Magrolimab in Combination With Azacitidine in Patients With Higher-Risk Myelodysplastic Syndromes: Final Results of a Phase Ib StudyDavid A Sallman, Monzr M Al Malki, Adam S Asch, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Current Hematologic Malignancy Reports|September 30, 2018
Leveraging Hypomethylating Agents for Better MDS TherapyTerrence J Bradley, Justin M Watts, Ronan T Swords
Cancer Management and Research|August 8, 2022
Profile of Glasdegib for the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML): Evidence to DateSunil Girish Iyer, Michele Stanchina, Terrence J Bradley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2021
Clinical Responsiveness to All-trans Retinoic Acid Is Potentiated by LSD1 Inhibition and Associated with a Quiescent Transcriptome in Myeloid MalignanciesMina M Tayari, Helena G Dos Santos, Deukwoo Kwon, et al.
Cancer|September 15, 2022
Molecular annotation of extramedullary acute myeloid leukemia identifies high prevalence of targetable mutationsSomedeb Ball, Todd C Knepper, Yehuda E Deutsch, et al.
Ejhaem|May 14, 2025
Phase 2 Multi-Arm Study of Magrolimab Combinations in Patients With Acute Myeloid LeukaemiaGabriel N Mannis, Camille N Abboud, Naval G Daver, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 13, 2023
Tolerability and Efficacy of the Anticluster of Differentiation 47 Antibody Magrolimab Combined With Azacitidine in Patients With Previously Untreated AML: Phase Ib ResultsNaval G Daver, Paresh Vyas, Suman Kambhampati, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 8, 2023
Magrolimab in Combination With Azacitidine in Patients With Higher-Risk Myelodysplastic Syndromes: Final Results of a Phase Ib StudyDavid A Sallman, Monzr M Al Malki, Adam S Asch, et al.
Pageof 1